CAPTRUST FINANCIAL ADVISORS - SUMMIT THERAPEUTICS PLC ownership

SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 2 filers reported holding SUMMIT THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of SUMMIT THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$90,174
+43.4%
35,9260.0%0.00%
Q1 2023$62,870
+383.6%
35,926
+219.5%
0.00%
Q3 2022$13,000
+18.2%
11,245
-1.7%
0.00%
Q2 2022$11,000
-60.7%
11,445
+1.8%
0.00%
Q1 2022$28,000
-6.7%
11,2450.0%0.00%
Q4 2021$30,000
-46.4%
11,2450.0%0.00%
Q3 2021$56,000
-33.3%
11,2450.0%0.00%
-100.0%
Q2 2021$84,000
+37.7%
11,245
+8.1%
0.00%0.0%
Q1 2021$61,000
+17.3%
10,400
-5.5%
0.00%0.0%
Q4 2020$52,000
+40.5%
11,0000.0%0.00%0.0%
Q3 2020$37,000
+5.7%
11,0000.0%0.00%0.0%
Q2 2020$35,00011,0000.00%
Other shareholders
SUMMIT THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Worth Asset Management, LLC 10,956$20,4880.02%
Lindbrook Capital, LLC 782$1,4620.00%
View complete list of SUMMIT THERAPEUTICS PLC shareholders